Key result
Baseline acetylcholine-induced renal artery dilation negatively correlated with lisinopril-induced reduction of proteinuria (r2=0.648, P=0.003) and decrease in SBP (r2=0.592, P=0.006) in rats.
Why the study?
Does baseline renal endothelial function predict the anti-proteinuric and blood pressure-lowering effect of lisinopril in a rat model of chronic kidney disease?
Does baseline renal endothelial function predict the anti-proteinuric and blood pressure-lowering effect of lisinopril in a rat model of chronic kidney disease?
Effect estimate: r2 = 0.648
p-value: p=0.003
In a rat model of chronic kidney disease, decreased basal renal endothelial-mediated vasodilation predicts a greater attenuation of renal damage and blood pressure reduction with ACE inhibitor therapy.
Endothelial variation may stratify renal injury risk in rat models; leaves open prediction of ACEI response in human CKD.
In healthy rats, the physiological variation of baseline endothelial function of intrarenal arteries correlates with the severity of renal damage in response to a subsequent specific renal injury. However, whether such a variation in endothelial function may also condition or predict the variable response to angiotensin-converting enzyme-inhibiting treatment in these individuals has not been addressed before. To study this, 5/6 nephrectomy was performed to induce renal injury and chronic kidney disease in a group of healthy Wistar rats. At the time of nephrectomy, interlobar arteries were obtained from the extirpated right kidney and studied in vitro for endothelium-dependent relaxation to acetylcholine. Six weeks thereafter, treatment with lisinopril was started (n = 11) and continued for 9 wk. Proteinuria (metabolic cages) and systolic blood pressure (SBP; tail cuff) were evaluated weekly, and these were analyzed in relation to renal endothelial function at baseline. 5/6 Nephrectomy induced an increase in SBP and progressive proteinuria. Treatment with lisinopril reduced SBP and slowed proteinuria, albeit to a variable degree among individuals. The acetylcholine-induced renal artery dilation at baseline negatively correlated with lisinopril-induced reduction of proteinuria (r(2) = 0.648, P = 0.003) and with the decrease in SBP (r(2) = 0.592, P = 0.006). Our data suggest that angiotensin-converting enzyme-inhibitor attenuates the progression of renal damage the most in those individuals with decreased basal renal endothelial-mediated vasodilation.
No takes yet. Share an insight, caveat, or question.
Vettoretti et al. (2016) studied Chronic kidney disease (n=11). Lisinopril was evaluated on Correlation between baseline acetylcholine-induced renal artery dilation and lisinopril-induced reduction of proteinuria (r2 = 0.648, p=0.003). Baseline acetylcholine-induced renal artery dilation negatively correlated with lisinopril-induced reduction of proteinuria (r2=0.648, P=0.003) and decrease in SBP (r2=0.592, P=0.006) in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: